IGXT - IntelGenx Technologies Corp.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 0.159

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.09 - $ 0.22

Volume

15,607

Average Volume

Market Cap

27.77M

Beta (5Y Monthly)

$ 0.83

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-21-2024	12-31-2023	10-K
2	11-09-2023	09-30-2023	10-Q
3	08-14-2023	06-30-2023	10-Q
4	05-11-2023	03-31-2023	10-Q
5	03-29-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	03-24-2022	12-31-2021	10-K
10	11-11-2021	09-30-2021	10-Q
11	08-04-2021	06-30-2021	10-Q
12	05-13-2021	03-31-2021	10-Q
13	03-25-2021	12-31-2020	10-K
14	11-12-2020	09-30-2020	10-Q
15	08-13-2020	06-30-2020	10-Q
16	05-14-2020	03-31-2020	10-Q
17	03-26-2020	12-31-2019	10-K
18	11-07-2019	09-30-2019	10-Q
19	08-08-2019	06-30-2019	10-Q
20	05-09-2019	03-31-2019	10-Q
21	03-22-2019	12-31-2018	10-K
22	11-08-2018	09-30-2018	10-Q
23	08-09-2018	06-30-2018	10-Q
24	05-10-2018	03-31-2018	10-Q
25	03-29-2018	12-31-2017	10-K
26	11-09-2017	09-30-2017	10-Q
27	08-10-2017	06-30-2017	10-Q
28	05-11-2017	03-31-2017	10-Q
29	03-28-2017	12-31-2016	10-K
30	11-10-2016	09-30-2016	10-Q
31	08-11-2016	06-30-2016	10-Q
32	05-10-2016	03-31-2016	10-Q
33	03-30-2016	12-31-2015	10-K
34	11-03-2015	09-30-2015	10-Q
35	08-10-2015	06-30-2015	10-Q
36	05-14-2015	03-31-2015	10-Q
37	03-31-2015	12-31-2014	10-K
38	11-12-2014	09-30-2014	10-Q
39	08-07-2014	06-30-2014	10-Q
40	05-13-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

psychedelics-headlines-mdma--coping-skills-in-ptsd-lsds-perceived-risks-knowledge-gaps-surveys--more

Psychedelics Headlines: MDMA & Coping Skil...
01/15/2024 18:38:32

Welcome to Benzinga's weekly psychedelics headlines roundup. This is our pick of must-read news items from the second week ...

Intelgenx Technologies Q3 EPS $(0.01) Up F...
11/09/2023 21:32:54

Intelgenx Technologies (OTC:IGXT) reported quarterly losses of $(0.01) per share. This is a 50 percent increase over losses of ...

IntelGenx Announces Co-Development And Com...
11/06/2023 13:34:09

IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it and Tilray Brands ...

intelgenx-q2-2023-revenue-decline-67-operating-costs-rise-what-about-net-loss

IntelGenx Q2 2023: Revenue Decline 67%, Op...
08/15/2023 02:54:20

IntelGenx Technologies Corp. (TSX: IGX) (OTC: IGXT), a drug delivery company focused on the development and manufacturing of ph...

Intelgenx Technologies Q2 EPS $(0.02), Sam...
08/14/2023 20:32:49

Intelgenx Technologies (OTC:IGXT) reported quarterly losses of $(0.02) per share. This is unchanged from the same period last y...

psyched-20m-research-fund-lsd-microdosing-for-cancer-meai-enters-clinical-stage-reform-update--more

Psyched: $20M Research Fund, LSD Microdosi...
05/15/2023 21:30:48

Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics rece...

fda-gives-nod-to-intelgenxs-migraine-solution-as-revenues-plunge-32-q1-results-report

FDA Gives Nod To IntelGenx's Migraine Solu...
05/11/2023 22:33:52

IntelGenx Technologies Corp. (OTC: IGXT) reported on Thursday a 32% decrease in total revenues for the first quarter of 2023, a...

Intelgenx Technologies Q1 EPS $(0.02), Sam...
05/11/2023 20:10:32

Intelgenx Technologies (OTC:IGXT) reported quarterly losses of $(0.02) per share. This is unchanged from the same period last y...

psyched-canadas-case-for-psilocybin-access-and-microdose-trial-us-reform-update-battle-with-dea--more

Psyched: Canada's Case For Psilocybin Acce...
04/05/2023 13:57:15

Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism A patient-led lawsui...

intelgenxs-q4-and-full-year-2022-financials-on-the-cusp-of-rapid-growth

IntelGenx's Q4 And Full-Year 2022 Financia...
03/30/2023 19:31:40

Drug delivery company IntelGenx Technologies Corp. (OTCQB: IGXT)’s financial results for the three and twelve months ended Dece...

Intelgenx Technologies Q4 EPS $(0.01) Up F...
03/30/2023 05:09:51

Intelgenx Technologies (OTC:IGXT) reported quarterly losses of $(0.01) per share. This is a 50 percent increase over losses of ...

GH Research, Mind Medicine Among Top Psych...
01/31/2023 21:30:06

Intelgenx Technologies, Cybin Among Top Ps...
01/30/2023 21:30:07

Cybin, GH Research Among Top Psychedelic M...
01/27/2023 21:30:05

Psychedelic Stock Gainers And Losers From ...
01/26/2023 21:30:06

Biomind Labs, Intelgenx Technologies Among...
01/25/2023 21:30:06

Psychedelic Stock Gainers And Losers From ...
01/24/2023 21:30:06

Psychedelic Stock Gainers And Losers From ...
01/19/2023 21:30:06

GH Research, Cybin Among Top Psychedelic M...
01/16/2023 21:30:05

Psychedelic Stock Gainers And Losers From ...
01/13/2023 21:30:06